Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
AY.43.5 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBC.1.6.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
FP.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.2.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.74NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.25NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.237NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBNNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBJ.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.356NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.462NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
A.29NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.147NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
P.1.6 (Gamma)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
P.1.5 (Gamma)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
P.1.4 (Gamma)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.420NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.2.12NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.39.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EK.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.233NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.24NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.320NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
C.33NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.635NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
C.21NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
C.14NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.19 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
N.4NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AM.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.15 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.113NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GA.10NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BF.5.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CA.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BM.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.2.46NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.5.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CU.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
CA.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.83NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.40NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.160.27NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AY.4.2.4 (Delta)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.161NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.58NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.177.75NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.411NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.217NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used